000 03459nam a22004455c 4500
999 _c6764
_d6764
001 6764
003 ES-MaUEC
005 20200630113830.0
006 a||||fo|||| 00| 0
007 cr nn 008mamaa
008 181206s2019 gw a s |||| 0|eng d
020 _a9783030035020
024 7 _a10.1007/978-3-030-03502-0
_2doi
040 _bspa
_cES-MaUEC
_dES-MaUEC
050 4 _aRC268.48
_b.H58 2019EB
245 0 0 _aHIV/AIDS-Associated Viral Oncogenesis
_cedited by Craig Meyers.
250 _a2nd ed. 2019.
264 1 _aCham
_bSpringer International Publishing :
_bImprint: Springer
_c2019.
300 _aVIII, 250 páginas 17 ilustraciones, 10 ilustraciones a color
336 _2rdacontent
_aTexto (visual)
_btxt
337 _2rdamedia
_aelectrónico
_bc
338 _2rdacarrier
_arecurso electrónico
_bcr
347 _atext file
_bPDF
_2rda
490 1 _aCancer Treatment and Research,
_x0927-3042 ;
_v177
490 0 _aMedicine (Springer-11650)
505 0 _aOverview -- HIVAIDS Malignancies -- Molecular Biology of KSHV in Relation to HIV/AIDS - Associated Oncogenesis -- KSHV-Associated Disease in the HIV/AIDS Patient -- Molecular Biology of EBV in Relationship to HIV/AIDS - Associated Oncogenesis -- EBV-Associated Diseases in HIV/AIDS Patient -- HPV-Associated Genital Cancer in the HIV/AIDS Patient -- HPV-Associated Oral Tumors and Cancer in the HIV/AIDS Patient -- HPV-Associated Anal Cancer in the HIV/AIDS Patient -- Merkel Cell Carcinoma in the HIV/AIDS Patient -- Polyomavirus SV40 and AIDS-Related Systemic Non-Hodgkin’s Lymphoma -- HIV-HBV and HIV-HCV Coinfection and Liver Cancer.
520 3 _aIn this book, leading experts examine the clinical and biological aspects of viruses known to play a role in the oncogenesis of AIDS-associated cancers and non-AIDS-defining malignancies more commonly observed in HIV-infected individuals. Among the malignancies considered are those associated with Kaposi sarcoma-associated herpesvirus (KSHV) or Epstein–Barr virus (EBV), Merkel cell carcinoma due to Merkel cell polyomavirus (MCPyV), human papillomavirus (HPV)-associated anogenital and oropharyngeal cancers, and hepatitis B and C virus (HBV/HCV)-associated liver cancers. It also provides detailed information on the molecular biology of the causative viral agents and guidance on the specific treatment required in this special population. Covering all the important advances in our understanding made since the first edition was published in 2007, including the discovery and characterization of MCPyV, which brought the number of known human oncoviruses to seven, this new edition is a valuable resource for members of the scientific and healthcare community and active researchers in this field.
988 _aPrimersemestre_2019_Medicine
653 0 _aOncology  .
653 0 _aEmerging infectious diseases.
653 0 _aImmunology.
700 1 _aMeyers, Craig.
_eeditor literario
_4edt
_4http://id.loc.gov/vocabulary/relators/edt
710 2 _aSpringerLink (Online service)
_9106937
776 0 8 _iPrinted edition:
_z9783030035013
776 0 8 _iPrinted edition:
_z9783030035037
830 0 _aCancer Treatment and Research,
_x0927-3042 ;
_v177
856 4 0 _uhttps://go.openathens.net/redirector/universidadeuropea.es?url=https://doi.org/10.1007/978-3-030-03502-0
_zAcceso a este recurso digital (usuarios Universidad Europea de Valencia)
942 _2lcc
_cLE
998 _db
_feng
_ggw
_h0
_el